Quebec Company Launches a First-Class Bilingual Experience with One-of-a-Kind Elements
MONT TREMBLANT, Quebec, Dec. 18, 2020 (GLOBE NEWSWIRE) — This September Karma Shala Yoga Inc. launched an online yoga business gaining the attention of the Canadian yoga community. The website has all the elements of leading international online yoga experiences, in addition to unique features, including interactive Question and Answers with instructors and special guests, along with Live Events. Karma Shala Online is supported by some of the best yoga teachers in Quebec and delivered in a completely bilingual format.
“Covid-19 forced us to think differently. We identified a need in the online yoga world and created something special for our community”, said Melisande Turpin, President, Karma Shala Yoga Inc. “We did not simply want to post yoga videos, but rather recreate the entire yoga studio experience online. We wanted to bring our community together during this difficult time and we could not be more pleased with the result.”
Karma Shala Online features:
Karma Shala Yoga Inc: https://www.karmashala.ca/ is a yoga studio and online yoga experience based in Mont Tremblant, Quebec. The company was founded in 2015 and has since become one of the leading studios in the province, hosting thousands of Canadian and international clients each year. The online component, Karma Shala Online, launched in September of 2020, https://online.karmashala.ca/
Jimmy Adduci
Karma Shala Yoga Inc.
819-430-6730
jimmy@karmashala.ca
Medical Device Developer & Investor Taps 4 Markets With Growth Projections of USD $39.1B by…
The round is led by Danish VC Dreamcraft, together with biotech investor Lundbeckfonden BioCapital and…
BCC Research Identifies Key Sectors with Substantial Growth Potential, Forecasting Significant Market Expansion Through 2029.…
PALO ALTO, CA / ACCESSWIRE / July 3, 2024 / Bioz, Inc., a pioneering AI…
STOCKHOLM, SWEDEN / ACCESSWIRE / July 3, 2024 / iZafe Group (STO:IZAFE-B.ST) iZafe Group AB…
GSK acquires full rights to develop, manufacture and commercialize globally mRNA candidate vaccines for influenza…